CMCSA
stock NASDAQKey stats
- Open
- $24.86
- -0.08%
- Close
- $25.08
- +0.80%
- Current
- $25.08
- Prev close
- $24.88
- Today
- 27.77M
- 3-mo avg
- 32.15M
Fundamentals
Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.
At 5x, the stock is priced cheaply against its profits: sometimes a bargain, sometimes a sign of trouble ahead.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 5.3% yield is a healthy, generally sustainable level of cash income.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 16.2% margin is strong; the company keeps a healthy slice of every revenue dollar.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 20.6% return on equity is strong; the company compounds owners' capital well.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 7.3% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
Not enough data to compute debt-to-equity.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 0.88, short-term assets fall short of short-term bills; liquidity is tight.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue fell 0.0% from the prior year; the top line is contracting.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 23.5% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financials
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $116.4B | $121.4B | $121.6B | $123.7B | $123.7B |
| Net income | $14.2B | $5.4B | $15.4B | $16.2B | $20.0B |
| Diluted EPS | $3.04 | $1.21 | $3.71 | $4.14 | $5.39 |
| Dividend / share | $1.00 | $1.08 | $1.16 | $1.24 | $1.32 |
| Total assets | $275.9B | $257.3B | $264.8B | $266.2B | $272.6B |
| Total liabilities | · | · | · | · | · |
| Shareholder equity | $97.5B | $81.6B | $83.2B | $85.6B | $96.9B |
| Q3-2023 | Q1-2024 | Q2-2024 | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $30.1B | $30.1B | $29.7B | $32.1B | $29.9B | $30.3B | $31.2B | $31.5B |
| Net income | $4.0B | $3.9B | $3.9B | $3.6B | $3.4B | $11.1B | $3.3B | $2.2B |
| Diluted EPS | $0.98 | $0.97 | $1.00 | $0.94 | $0.89 | $2.98 | $0.90 | $0.60 |
| Dividend / share | $0.29 | $0.31 | $0.31 | $0.31 | $0.33 | $0.33 | $0.33 | $0.33 |
Recent SEC filings
- DEF 14A Proxy statement
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report